Sign inJoin waitlistJoin the waitlist

Mark Stegall

Director · Mayo Clinic College of Medicine and Science

Credentials: · · ·

History

Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present
Mayo Clinic College of Medicine and Science
Present

Vascular Surgery
University of Wisconsin Hospitals and Clinics
1989–1991
Research Fellowship The Presbyterian Hospital
Surgery The Presbyterian Hospital
1982–1989
Mayo Clinic
1979–1982
Columbia Univ Coll of Phys & Surgeons
1975–1979

Research

Risk factors for primary dysfunction after liver transplantation--a multivariate analysis
Transplantation · 1993 · 889 citations
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints…
American Journal of Transplantation · 2018 · 865 citations
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection
American Journal of Transplantation · 2020 · 740 citations

Fernando Cosio
73 papers
PD
Patrick Dean
65 papers · 4 as a resident
JG
James Gloor
62 papers
Timothy Larson
55 papers
Carrie Schinstock
47 papers · 4 as a resident
Mikel Prieto
46 papers
Matthew Griffin
39 papers
LC
Lynn Cornell
35 papers
Andrew Bentall
32 papers · 18 as a resident
Hatem Amer
32 papers · 7 as a fellow
Scott Nyberg
28 papers
ST
Stephen Textor
27 papers

Grants

Intragraft Expression to Predict Future GFR Decline in Kidney Transplantation
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $3.4M · Mayo Clinic Rochester
2011–2019
Maintenance and Targeting of Bone Marrow Derived Allo-Reactive Human Plasma Cells
National Institute of Allergy and Infectious Diseases · R21
PI · $437.3K · Mayo Clinic Rochester
2016–2018
Chronic Antibody-Mediated Injury in Renal Allografts
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $897.2K · Mayo Clinic Rochester
2010–2015
vla4 in Ctl Mediated Islet Allograft Rejection
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $786.8K · Mayo Clinic Rochester
1999–2002

Clinical trials

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.
Principal investigator · Recruiting · Phase 4
Mayo Clinic
2025–2031
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
Principal investigator · Terminated · Phase 3
Mark Stegall
2022–2025
Envarsus XR Compared to Immediate Release Tacrolimus
Principal investigator · Completed · Phase 4
Mayo Clinic
2019–2022
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation
Principal investigator · Completed · Phase 2
Mayo Clinic
2019–2021